Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials

BACKGROUND: Ertapenem, a new carbapenem with a favorable pharmacokinetic profile, has been approved for the treatment of complicated intra-abdominal Infections (cIAIs), acute pelvic infections (APIs) and complicated skin and skin-structure infections (cSSSIs). The aim of this study is to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Mao Mao, Zou, Zui, Shen, Hui, Zhang, Jun Dong, Chen, Meng Li, Liu, Ping, Wang, Rui, Jiang, Yuan Ying
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794873/
https://www.ncbi.nlm.nih.gov/pubmed/19951447
http://dx.doi.org/10.1186/1471-2334-9-193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794873/
https://www.ncbi.nlm.nih.gov/pubmed/19951447
http://dx.doi.org/10.1186/1471-2334-9-193

Ejemplares similares